When was Boltzmann founded?

Boltzmann was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Boltzmann located?

Boltzmann is headquartered in Bengaluru, India. It is registered at 2-178, Kolluru P O bypass Road, Guntur, KOLLURU, Andhra Pradesh, India, 522324.

Who is the current CEO of Boltzmann?

Kolli Sarath of Boltzmann. They have also founded 2 companies.

Which legal entities is Boltzmann associated with?

Boltzmann is associated with BOLTZMANN LABS PRIVATE LIMITED.

How many employees does Boltzmann have?

As of Sep 30, 2026, the latest employee count at Boltzmann is 39.

Is Boltzmann a funded company?

Boltzmann is a funded company, having raised a total of $340K across 10 funding rounds to date. The company's 1st funding round was a $***** Angel round, raised on Mar 19, 2021.

How much is Boltzmann worth?

The latest valuation of Boltzmann is $***** as of Mar 26, 2026.

When was the latest funding round of Boltzmann?

Boltzmann's latest funding was a $***** Seed round on Mar 26, 2026, with participation from 1 investor.

What is the annual revenue of Boltzmann?

Annual revenue of Boltzmann is less than ₹10 Cr as on Mar 31, 2026

Where does Boltzmann rank among its competitors?

Boltzmann ranks 56th amongst 289 active competitors, of which 88 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Iambic Therapeutics, which secured $66M in Aug, 2026.

Who are the top competitors of Boltzmann?

Boltzmann's top competitors include Schrodinger, Relay Therapeutics and XtalPi. Among them, Iambic Therapeutics secured the most recent funding round in August, 2026.

Boltzmann - 2026 Company Profile, Team, Funding, Competitors & Financials

Boltzmann is a seed company based in Bengaluru (India), founded in 2019 by Kolli Sarath and Paritosh Prashar. It operates as an AI powered drug discovery platform for cancer and autoimmune diseases. Boltzmann has raised $340K in funding from SINE and Angel List, with a current valuation of $*****. The company has 289 active competitors, including 88 funded and 16 that have exited. Its top competitors include companies like Schrodinger, Relay Therapeutics and XtalPi.

Company Details

AI powered drug discovery platform for cancer and autoimmune diseases. The platform offers boltchem a small molecule design and discovery software, ReBolt a synthesis planning tool to accelerate the process of synthesis, Boltbio for multi-omic analysis, BoltPro to engineer proteins, peptide drugs, and antibodies, and Clinbolt is an AI powered platform for clinical trial design as well as biosimulation for personalized medicine.

Website: boltzmann.co
Social
Email ID: *****@boltzamnn.co
Phone Number: +91 **********
Registered Address: 2-178, Kolluru P O bypass Road, Guntur, KOLLURU, Andhra Pradesh, India, 522324

Key Metrics

Founded Year

2019

Location

Bengaluru, India

Stage

Seed

Total Funding

$340K in 10 rounds

Latest Funding Round

Seed, Mar 26, 2026, $*****

Post Money Valuation

$***** as on Mar 26, 2026

Investors

SINE & 25 more

Ranked

56^th among 289 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2026

Employee Count

39 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3110 more

View Boltzmann's full profile

Boltzmann is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
BOLTZMANN LABS PRIVATE LIMITED CIN: U73100AP2019PTC111816 , India, Active	May 02, 2019	0 - ₹10 Cr (As on Mar 31, 2026)	3 (As on Mar 01, 2025)

Boltzmann has raised a total funding of $340K over 10 rounds. Its first funding round was on Mar 19, 2021. Its latest funding round was a Seed round on Mar 26, 2026 for $*****. 1 investor participated in its latest round. Boltzmann has 4 institutional investors and 22 angel investors.

Here is the list of recent funding rounds of Boltzmann:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 26, 2026	1120233	Seed	2644739	5995789	2508859	9493770
Sep 05, 2025	7317218	Seed	8804707	1816219	6819208	6138138
Mar 31, 2025	9722896	Seed	4238186	6554480	Angel List	5692081

Access funding benchmarks and valuations. Sign up today!

View details of Boltzmann's funding rounds and investors

The founders of Boltzmann are Kolli Sarath and Paritosh Prashar. Kolli Sarath is the CEO of Boltzmann.

Here are the details of Boltzmann's key team members:

Kolli Sarath: Co-Founder & CEO of Boltzmann and founder of 2 other companies, Boltchem and Bayes Labs. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Paritosh Prashar: Co-Founder & CSO of Boltzmann. They serve on the board of 1 company.
Contact Info: 1 email address

Boltzmann's Board of Directors

Boltzmann's board has 2 active members. Kolli Sarath and Paritosh Prashar are part of team.

Here is the list of Boltzmann's board of directors:

Name	Type	Representing	Status	Duration
Kolli Sarath	Team	-	Current	7y 5m
Paritosh Prashar	Team	-	Current	3y 4m

View details of Boltzmann's Founder profiles and Board Members

Boltzmann's employee count trend

Boltzmann has 39 employees as of Sep 26. Here is Boltzmann's employee count trend over the years:

Uncover Boltzmann's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Boltzmann include Schrodinger, Relay Therapeutics and XtalPi. Here is the list of Top 10 competitors of Boltzmann, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	72/100
2nd	Relay Therapeutics 2016, Cambridge (United States), Public	Developer of drug discovery platform and study protein motion	$520M	BVF Partners, SoftBank Vision Fund & 17 others	69/100
3rd	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	69/100
4th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	69/100
5th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	65/100
6th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	64/100
7th	Iambic Therapeutics 2019, San Diego (United States), Public	Provider of AI-driven drug discovery platform for the treatment of cancer	$334M	Abingworth, Exor & 26 others	64/100
8th	Genesis Therapeutics 2019, San Francisco (United States), Series B	Developer of an AI platform for discovering and designing novel drugs	$304M	Andreessen Horowitz, Rock Springs Capital ... & 16 others	64/100
9th	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 48 others	64/100
10th	Aqemia 2019, Paris (France), Series A	Provider of an AI and quantum physics to discover therapeutic molecules	$101M	Cathay Innovation, Elaia & 4 others	63/100
56th	Boltzmann 2019, Bengaluru (India), Seed	AI powered drug discovery platform for cancer and autoimmune diseases	$340K	ML Elevate, SINE & 24 others	40/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Boltzmann's competitors? Click here to see the top ones

Founders (largest shareholder) own 67.24%, Funds own 3.22%, Angels own 4.96% and Other People own 3.33%. The net worth of Boltzmann's founders is INR 32.7Cr as of Mar 26, 2026. The cap table displayed below is for BOLTZMANN LABS PRIVATE LIMITED which is the legal entity associated with Boltzmann.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	67.24%	32.7Cr	4707131	7235104	9943130	5061267
Kolli Sarath	1294600	5417943	3681436	6255507	3429501	4185643
Paritosh Prashar	4840566	2181974	6653149	6566252	4344512	3979622
Fund	3.22%	1.56Cr	266	460	888	153
SINE	75	10	55	95	85	26
Angel List	2	3	4	6	3	4
Angel	4.96%	2.41Cr	3152	2229	3453	7746
Sundeep Sareen	0	0	0	0	0	0
Other People	3.33%	1.62Cr	222	900	873	145
ESOP Pool	21.26%	10.3Cr	1803583	1703142	7898940	9121660
Total	100.00%	48.6Cr	7202863	3939679	7262390	8330238